EICHORCondition: Diffuse Large B-Cell Lymphoma · Follicular Lymphoma · Marginal Zone Lymphoma · Sponsor: TG Therapeutics, Inc.
Unity NHL - A Phase 2b Randomized Study to Assess the Efficacy and Safety of the Combination of Ublituximab + Umbralisib with or without Bendamustine and Umbralisib alone in Patients with Previously Treated Non-Hodgkin's Lymphoma
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Inclusion Criteria: * Diagnosis of Non-Hodgkin's Lymphoma including Follicular, Mantle Cell Lymphoma and Marginal Zone Lymphoma * Relapsed or refractory to prior standard therapy and subjects who are not candidates for high-dose therapy or autologous stem cell transplant * MCL subjects with one or more lines of therapy including at least one BTK inhibitor (ibrutinib, acalabrutinib or zanibrutinib only) Exclusion Criteria: * Any major surgery, chemotherapy or immunotherapy within the last 21 days * Evidence of hepatitis B virus, hepatitis C virus or known HIV infection * Autologous hematologic stem cell transplant within 6 months of study entry. Prior Allogeneic hematologic stem cell transplant is excluded * Prior therapy with a PI3K delta inhibitor
Reproduced word-for-word from the public registry record — the study team can answer questions about it.
| TG Therapeutics Investigational Trial Site | Birmingham, Alabama, United States | — |
| TG Therapeutics Investigational Trial Site | Huntsville, Alabama, United States | — |
| TG Therapeutics Investigational Trial Site | Chandler, Arizona, United States | — |
| TG Therapeutics Investigational Trial Site | Tucson, Arizona, United States | — |
| TG Therapeutics Investigational Trial Site | Tucson, Arizona, United States | — |
| TG Therapeutics Investigational Trial Site | Los Angeles, California, United States | — |
| TG Therapeutics Investigational Trial Site | Orange, California, United States | — |
| TG Therapeutics Investigational Trial Site | San Diego, California, United States | — |
| TG Therapeutics Investigational Trial Site | San Diego, California, United States | — |
| TG Therapeutics Investigational Trial Site | Whittier, California, United States | — |
| TG Therapeutics Investigational Trial Site | Aurora, Colorado, United States | — |
| TG Therapeutics Investigational Trial Site | Denver, Colorado, United States | — |
+ 156 more locations — full list on the registry record.
This study lists sites in the areas below. Each link shows other recruiting studies near that city, from the public registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT02793583